Primecap Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $867M | Sell |
|
|||||
|
2025
Q1 | $1.26B | Sell |
|
|||||
|
2024
Q4 | $1.2B | Sell |
|
|||||
|
2024
Q3 | $1.33B | Buy |
|
|||||
|
2024
Q2 | $1.55B | Buy |
|
|||||
|
2024
Q1 | $1.63B | Buy |
|
|||||
|
2023
Q4 | $1.78B | Buy |
|
|||||
|
2023
Q3 | $1.63B | Buy |
|
|||||
|
2023
Q2 | $1.59B | Buy |
|
|||||
|
2023
Q1 | $1.77B | Buy |
|
|||||
|
2022
Q4 | $1.82B | Sell |
|
|||||
|
2022
Q3 | $1.49B | Sell |
|
|||||
|
2022
Q2 | $1.47B | Sell |
|
|||||
|
2022
Q1 | $1.37B | Sell |
|
|||||
|
2021
Q4 | $1.57B | Sell |
|
|||||
|
2021
Q3 | $1.39B | Sell |
|
|||||
|
2021
Q2 | $1.5B | Sell |
|
|||||
|
2021
Q1 | $1.37B | Buy |
|
|||||
|
2020
Q4 | $1.59B | Sell |
|
|||||
|
2020
Q3 | $1.38B | Buy |
|
|||||
|
2020
Q2 | $2.21B | Buy |
|
|||||
|
2020
Q1 | $1.5B | Buy |
|
|||||
|
2019
Q4 | $1.38B | Buy |
|
|||||
|
2019
Q3 | $1.02B | Buy |
|
|||||
|
2019
Q2 | $1.22B | Buy |
|
|||||
|
2019
Q1 | $1.26B | Buy |
|
|||||
|
2018
Q4 | $1.21B | Sell |
|
|||||
|
2018
Q3 | $1.38B | Sell |
|
|||||
|
2018
Q2 | $1.34B | Buy |
|
|||||
|
2018
Q1 | $1.12B | Buy |
|
|||||
|
2017
Q4 | $914M | Buy |
|
|||||
|
2017
Q3 | $897M | Buy |
|
|||||
|
2017
Q2 | $846M | Buy |
|
|||||
|
2017
Q1 | $765M | Buy |
|
|||||
|
2016
Q4 | $653M | Buy |
|
|||||
|
2016
Q3 | $658M | Sell |
|
|||||
|
2016
Q2 | $569M | Sell |
|
|||||
|
2016
Q1 | $606M | Buy |
|
|||||
|
2015
Q4 | $768M | Sell |
|
|||||
|
2015
Q3 | $776M | Sell |
|
|||||
|
2015
Q2 | $1.09B | Sell |
|
|||||
|
2015
Q1 | $1B | Buy |
|
|||||
|
2014
Q4 | $725M | Sell |
|
|||||
|
2014
Q3 | $580M | Sell |
|
|||||
|
2014
Q2 | $502M | Sell |
|
|||||
|
2014
Q1 | $557M | Buy |
|
|||||
|
2013
Q4 | $532M | Sell |
|
|||||
|
2013
Q3 | $549M | Sell |
|
|||||
|
2013
Q2 | $429M | Buy |
|